Article
A highly annotated database of genes associated with platinum resistance in cancer
13 Oct 2021
Abstract excerpt
Platinum-based chemotherapy, including cisplatin, carboplatin, and oxaliplatin, is prescribed to 10-20% of all cancer patients. Unfortunately, platinum resistance develops in a significant number of patients and is a determinant of clinical outcome. Extensive research has been conducted to understand and overcome platinum resistance, and mechanisms of resistance can be categorized into several broad biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
